Table 1 |
|||||
|
Estrogen-regulated probe sets that are differentially expressed in wounds from elderly compared to young subjects |
|||||
| Affy ID |
Gene* |
Gene (description) |
Function |
q-value† |
FC‡ |
|
|
|||||
| Down-regulated probe sets (65) |
|||||
| 207720_at |
LOR |
loricrin |
Major cornified envelope protein |
0 |
-235 |
| 201909_at |
RPS4Y1 |
ribosomal protein S4, Y-linked 1 |
40S ribosomal component |
0 |
-142 |
| 215704_at |
FLG |
filaggrin |
Cornified envelope-keratin linker |
9.4E-13 |
-114 |
| 206177_s_at |
ARG1 |
arginase, liver |
Delayed healing-associated |
9.2E-11 |
-82.0 |
| 206643_at |
HAL |
histidine ammonia-lyase |
Histidine catabolism |
1.5E-10 |
-59.0 |
| 206421_s_at |
SERPINB7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
Proteinase inhibitor for plasmin |
5.9E-13 |
-47.6 |
| 206192_at |
CDSN |
Corneodesmosin |
Desquamation/adhesion |
2.5E-06 |
-30.1 |
| 213796_at |
SPRR1A |
small proline-rich protein 1A |
Cornified envelope precursor protein |
1.5E-05 |
-29.4 |
| 207324_s_at |
DSC1 |
desmocollin 1 |
Desmosomal cadherin/adhesion |
9.6E-06 |
-28.9 |
| 209719_x_at |
SERPINB3 |
serpin peptidase inhibitor, clade B (ovalbumin), member 3 |
Inflammation and cancer-associated |
1.6E-05 |
-22.4 |
| 217496_s_at |
IDE |
insulin-degrading enzyme |
Wound fluid/resolution of insulin response |
4.0E-06 |
-20.5 |
| 211597_s_at |
HOP |
homeodomain-only protein |
Serum response factor binding |
1.7E-04 |
-19.7 |
| 211726_s_at |
FMO2 |
flavin containing monooxygenase 2 (non-functional) |
Non-functional oxidative enzyme |
7.0E-04 |
-18.9 |
| 220414_at |
CALML5 |
calmodulin-like 5 |
Epidermal-associated calcium-binding |
2.0E-05 |
-17.7 |
| 203328_x_at |
IDE |
insulin-degrading enzyme |
Wound fluid/resolution of insulin response |
1.4E-05 |
-17.4 |
| 210413_x_at |
SERPINB4 |
serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
Cancer and inflammation-associated |
3.1E-05 |
-15.8 |
| 219795_at |
SLC6A14 |
solute carrier family 6 (amino acid transporter), member 14 |
Amino acid transport/obesity |
6.9E-04 |
-15.6 |
| 210074_at |
CTSL2 |
cathepsin L2 |
Lysosomal cysteine proteinase |
3.8E-05 |
-15.5 |
| 222242_s_at |
KLK5 |
kallikrein 5 |
Desquamation, angiogenesis and cancer |
4.0E-05 |
-15.0 |
| 201348_at |
GPX3 |
glutathione peroxidase 3 (plasma) |
Protection from oxidative damage |
1.2E-05 |
-14.8 |
| 202018_s_at |
LTF |
lactotransferrin |
Inflammatory-cell-derived antioxidant |
4.6E-02 |
-14.5 |
| 205185_at |
SPINK5 |
serine peptidase inhibitor, Kazal type 5 |
Anti-inflammatory/anti-microbial |
3.8E-05 |
-14.4 |
| 211906_s_at |
SERPINB4 |
serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
Cancer and inflammation-associated |
5.7E-05 |
-12.4 |
| 219232_s_at |
EGLN3 |
egl nine homolog 3 (C. elegans) |
Hypoxia-inducible apoptosis-inducing |
1.4E-05 |
-12.1 |
| 213256_at |
MARCH3 |
membrane-associated ring finger (C3HC4) 3 |
Poorly characterized ubiquitin ligase |
1.6E-05 |
-12.1 |
| 204733_at |
KLK6 |
kallikrein 6 (neurosin, zyme) |
Hormone regulated serine protease |
1.4E-05 |
-11.9 |
| 202179_at |
BLMH |
bleomycin hydrolase |
Cysteine peptidase |
2.1E-03 |
-11.8 |
| 214549_x_at |
SPRR1A |
small proline-rich protein 1A |
Cornified envelope precursor protein |
1.6E-04 |
-11.3 |
| 207908_at |
KRT2 |
keratin 2 (epidermal ichthyosis bullosa of Siemens) |
Supra-basally expressed cytokeratin |
1.2E-03 |
-11.1 |
| 210338_s_at |
HSPA8 |
heat shock 70 kDa protein 8 |
ERalpha-inhibiting heat shock protein |
9.9E-04 |
-10.6 |
| 209720_s_at |
SERPINB3 |
serpin peptidase inhibitor, clade B (ovalbumin), member 3 |
Inflammation and cancer-associated |
3.3E-04 |
-10.5 |
| 201849_at |
BNIP3 |
BCL2/adenovirus E1B 19 kDa interacting protein 3 |
Mitochondrial apoptosis-inducing |
2.7E-04 |
-10.1 |
| 205916_at |
S100A7 |
S100 calcium binding protein A7 |
Chemotactic psoriasis-associated protein |
1.7E-04 |
-10.0 |
| 204952_at |
LYPD3 |
LY6/PLAUR domain containing 3 |
Upregulated in migrating keratinocytes |
1.2E-03 |
-9.7 |
| 206595_at |
CST6 |
cystatin E/M |
Cysteine protease inhibitor |
1.7E-06 |
-9.3 |
| 203327_at |
IDE |
insulin-degrading enzyme |
Wound fluid/resolution of insulin response |
7.0E-04 |
-9.3 |
| 209555_s_at |
CD36 |
CD36 molecule |
Thrombospondin receptor |
4.0E-03 |
-9.2 |
| 219532_at |
ELOVL4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
Skin barrier-promoting fatty acid elongase |
1.5E-05 |
-9.2 |
| 209126_x_at |
KRT6B |
keratin 6B |
Injury-associated keratin |
1.7E-03 |
-9.1 |
| 212573_at |
ENDOD1 |
endonuclease domain containing 1 |
Unknown |
8.3E-04 |
-9.0 |
| 214599_at |
IVL |
involucrin |
Early cornified envelope protein |
2.8E-03 |
-8.8 |
| 209218_at |
SQLE |
squalene epoxidase |
Rate-limiting sterol biosynthesis enzyme |
7.2E-04 |
-8.8 |
| 207356_at |
DEFB4 |
defensin, beta 4 |
Antimicrobial peptide |
6.0E-03 |
-8.8 |
| 210138_at |
RGS20 |
regulator of G-protein signaling 20 |
GTPase-activating protein |
8.1E-04 |
-8.7 |
| 202504_at |
TRIM29 |
tripartite motif-containing 29 |
Cancer-associated transcription factor |
2.2E-03 |
-8.6 |
| 205016_at |
TGFA |
transforming growth factor, alpha |
IFN-induced/epidermal regeneration |
1.0E-03 |
-8.5 |
| 209309_at |
AZGP1 |
alpha-2-glycoprotein 1, zinc |
TNFA-regulated prostate-cancer marker |
3.5E-04 |
-8.5 |
| 209800_at |
KRT16 |
keratin 16 (focal non-epidermolytic palmoplantar keratoderma) |
Hyperproliferation and healing-associated keratin |
1.2E-03 |
-8.3 |
| 205778_at |
KLK7 |
kallikrein 7 (chymotryptic, stratum corneum) |
Innate immunity/desquamation |
1.2E-05 |
-8.3 |
| 219756_s_at |
POF1B |
premature ovarian failure, 1B |
Unknown |
3.9E-05 |
-8.1 |
| 214091_s_at |
GPX3 |
glutathione peroxidase 3 (plasma) |
Protection from oxidative damage |
3.0E-03 |
-8.1 |
| 203585_at |
ZNF185 |
zinc finger protein 185 (LIM domain) |
Actin-associated tumor suppressor |
1.4E-03 |
-8.1 |
| 206008_at |
TGM1 |
transglutaminase 1 |
CE formation/epidermal differentiation |
4.6E-05 |
-8.0 |
| 202037_s_at |
SFRP1 |
secreted frizzled-related protein 1 |
Repressor of WNT signaling |
6.6E-04 |
-7.9 |
| 202539_s_at |
HMGCR |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
Rate-limiting cholesterol synthesis enzyme |
7.4E-04 |
-7.8 |
| 203575_at |
CSNK2A2 |
casein kinase 2, alpha prime polypeptide |
p53 phosphorylation, WNT signaling |
4.6E-04 |
-7.7 |
| 206884_s_at |
SCEL |
sciellin |
Cornified envelope precursor protein |
2.1E-04 |
-7.5 |
| 204284_at |
PPP1R3C |
protein phosphatase 1, regulatory (inhibitor) subunit 3C |
Regulates a wide variety of cellular functions |
9.9E-04 |
-7.4 |
| 266_s_at |
CD24 |
CD24 molecule |
Marker for epithelial neoplasms |
2.7E-04 |
-7.4 |
| 203914_x_at |
HPGD |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
Main enzyme for prostaglandin degradation |
1.6E-04 |
-7.3 |
| 219410_at |
TMEM45A |
transmembrane protein 45A |
Hox-regulated/reproductive tissue expressed |
8.1E-04 |
-7.3 |
| 206488_s_at |
CD36 |
CD36 molecule |
Thrombospondin receptor |
1.2E-05 |
-7.3 |
| 204881_s_at |
UGCG |
UDP-glucose ceramide glucosyltransferase |
Keratinocyte glucosyltransferase |
1.8E-03 |
-7.1 |
| 213933_at |
PTGER3 |
prostaglandin E receptor 3 (subtype EP3) |
Impaired wound healing in null mouse |
8.3E-04 |
-7.1 |
| 216379_x_at |
CD24 |
CD24 molecule |
Marker for epithelial neoplasms |
7.9E-04 |
-7.0 |
| Up-regulated probe sets (8) |
|||||
| 221728_x_at |
XIST |
X (inactive)-specific transcript |
X chromosome inactivation |
2.4E-12 |
191.8 |
| 214218_s_at |
XIST |
X (inactive)-specific transcript |
X chromosome inactivation |
1.0E-09 |
56.2 |
| 206211_at |
SELE |
selectin E (endothelial adhesion molecule 1) |
Endothelial-leukocyte adhesion |
9.0E-02 |
8.5 |
| 211600_at |
PTPRO |
protein tyrosine phosphatase, receptor type, O |
New marker of podocyte injury |
5.0E-04 |
8.4 |
| 220940_at |
KIAA1641 |
KIAA1641 |
Unknown |
1.0E-04 |
8.3 |
| 203915_at |
CXCL9 |
chemokine (C-X-C motif) ligand 9 |
Interferon induced, TH1 response |
6.3E-02 |
7.3 |
| 204324_s_at |
GOLPH4 |
golgi phosphoprotein 4 |
Protein export |
8.3E-04 |
7.3 |
| 201205_at |
RRBP1 |
ribosome binding protein 1 homolog 180 kDa (dog) |
Developmentally regulated extracellular matrix glycoprotein |
6.3E-03 |
7.3 |
|
|
|||||
|
*Genes in bold have been validated by qPCR. †CyberT-derived multiple testing corrected q-value. ‡Fold change (old/young). |
|||||
|
Hardman and Ashcroft Genome Biology 2008 9:R80 doi:10.1186/gb-2008-9-5-r80 |
|||||